Compared with PA, PA-S14 is at low toxicity and no inhibitory effects on complex I. Interestingly, we found PA-S14 serves as a new LKB1 activator, which effectively retards renal fibrosis through AMPK-mediated autophagy and mitochondrial homeostasis. Here, PRKAA1 is linked to renal fibrosis.